TIL
TIL
NASDAQ · Biotechnology

Instil Bio Inc

$7.76
+0.30 (+4.02%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 12.19M 11.47M 10.10M
Net Income 876.0K 905.7K 740.1K
EPS
Profit Margin 7.2% 7.9% 7.3%
Rev Growth +7.7% +14.6% +19.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 22.74M 26.22M 27.61M
Total Equity 17.95M 19.41M 20.13M
D/E Ratio 1.27 1.35 1.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 1.90M 1.88M 1.67M
Free Cash Flow 486.5K 519.3K 559.1K